On the Rise of Cyclin-Dependent Kinase Inhibitors in Breast Cancer:
Progress & Ongoing Challenges
Breast Cancer Manag
.
2020 Jun;9(2):BMT37.
doi: 10.2217/bmt-2020-0005.
Epub 2020 Apr 30.
Authors
Igor Makhlin
1
,
Angela DeMichele
1
Affiliation
1
Department of Medicine, Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania.
PMID:
34475968
PMCID:
PMC8409318
DOI:
10.2217/bmt-2020-0005
No abstract available
Grants and funding
T32 CA009615/CA/NCI NIH HHS/United States